Quarterly report pursuant to sections 13 or 15(d)

Condensed Statements of Operations and Comprehensive Loss

v2.4.0.8
Condensed Statements of Operations and Comprehensive Loss (USD $)
In Thousands, except Share data, unless otherwise specified
3 Months Ended
Mar. 31, 2014
Mar. 31, 2013
Operating expenses:    
Research and development $ 2,615 $ 1,490
General and administrative 2,500 925
Total operating expenses 5,115 2,415
Loss from operations (5,115) (2,415)
Other income (expense):    
Interest income 12 1
Interest expense (184) (212)
Other expense, net (4,775) (2)
Net loss (10,062) (2,628)
Accretion to redemption value of redeemable convertible preferred stock   (3,109)
Net loss attributable to common stockholders (10,062) (5,737)
Other comprehensive loss/income:    
Unrealized gain on marketable securities 1  
Other comprehensive income 1  
Comprehensive loss $ (10,061) $ (5,737)
Basic and diluted net loss per common share $ (1.02) $ (985.06)
Weighted average common shares outstanding used to calculate basic and diluted net loss per common share 9,873,687 5,824